Suleiman Azza Said MD Arlington Heights, IL - 60004

Suleiman Azza Said MD is categorized under Physicians Offices in Arlington Heights, IL and active since 2007.

Suleiman Azza Said MD was established in 2007, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Physicians Offices business, which does work in the B2C market, and is classified as a Physicians Offices, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Azza Said Suleiman at the company’s single location by writing to 1430 North Arlington Heights Road # 114, Arlington Heights, Illinois IL 60004 or by phoning (847) 394-1843. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Suleiman Azza Said MD
Contact Person: Azza Said Suleiman
Address: 1430 North Arlington Heights Road # 114, Arlington Heights, Illinois 60004
Phone Number: (847) 394-1843
Annual Revenue (USD): $500.000 to $999.999
Founded: 2007
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Physicians Offices
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Suleiman Azza Said MD was started in 2007 to provide professional Physicians Offices under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Azza Said Suleiman for inquiries that concern Suleiman Azza Said MD by calling the company number (847) 394-1843, as your correspondence is most welcome. Additionally, the physical location of the single location of Suleiman Azza Said MD can be found at the coordinates 42.101513,-87.980518 as well as the street address 1430 North Arlington Heights Road # 114 in Arlington Heights, Illinois 60004.

For its online presence, you may visit Suleiman Azza Said MD’s website at and engage with its social media outlets through on Twitter and on Facebook.